Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics of progesterone in pregnancy
NCT04753957Phase 1Terminated
- Sponsor
- Thomas Jefferson University
- Start
- Jan 2022
- Primary completion
- Feb 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of progesterone (2 arms), sponsored by Thomas Jefferson University. Primary endpoints: Endometrial (ng/mg) progesterone time/concentration profile at 12 hours and Plasma (ng/ml) progesterone time/concentration profile at 12 hours. Started Jan 2022; status: terminated.
02
Drugs
progesterone
Beyond the preview
Go deeper on NCT04753957.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04753957.